This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (60)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Double-blind Study With Quantified Data Processing

Paul Trouillas, MD; Frédérique Brudon, MD; Patrice Adeleine, PhD

Arch Neurol. 1988;45(11):1217-1222.

Abstract
• Some features of cerebellar ataxia have been reported to regress partially with long-term administration of 5-hydroxytryptophan or levorotatory form of 5-hydroxytryptophan. To test this effect further, 30 patients with various inherited or acquired cerebellar ataxias underwent a randomized, double-blind trial of placebo, and the levorotatory form of 5-hydroxytryptophan taken orally for four months. The levorotatory form of 5-hydroxytryptophan significantly improved the ataxia score. It also significantly modified the time of standing upright, the spread of feet, the speed of walking, speaking, and writing. In five cases in which the levorotatory form of 5-hydroxytryptophan therapy was maintained for 12 months, the effect continued progressively.

Author Affiliations
From the Neurology Service and Ataxia Research Center, Hôpital Neurologique, Alexis Carrel Faculty of Medicine, Lyon, France.

Footnotes
Accepted for publication March 21, 1988.

Reprint requests to Service de Neurologie, Hôpital Neurologique, 59 Blvd Pinel, 69003 Lyon, France (Dr Trouillas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale
Subramony et al.
Neurology 2005;64:1261-1262.
ABSTRACT | FULL TEXT  

Can We Treat Respiratory Failure in Friedreich Ataxia?
Botez et al.
Arch Neurol 1997;54:1030-1033.
ABSTRACT  

Buspirone, a 5-Hydroxytryptamine1A Agonist, Is Active in Cerebellar Ataxia: Results of a Double-blind Drug Placebo Study in Patients With Cerebellar Cortical Atrophy
Trouillas et al.
Arch Neurol 1997;54:749-752.
ABSTRACT  

Use of Buspirone for Treatment of Cerebellar Ataxia: An Open-Label Study
Lou et al.
Arch Neurol 1995;52:982-988.
ABSTRACT  

Treatment of Hereditary Ataxia With the Levorotatory Form of Hydroxytryptophan
Currier et al.
Arch Neurol 1995;52:440-441.
ABSTRACT  

Double-blind Crossover Study With Levorotatory Form of Hydroxytryptophan in Patients With Degenerative Cerebellar Diseases
Wessel et al.
Arch Neurol 1995;52:451-455.
ABSTRACT  

Levorotatory Form of 5-Hydroxytryptophan in Friedreich's Ataxia: Results of a Double-blind Drug-Placebo Cooperative Study
Trouillas et al.
Arch Neurol 1995;52:456-460.
ABSTRACT  

Autoantibodies to Glutamate Decarboxylase in a Patient With Cerebellar Cortical Atrophy, Peripheral Neuropathy, and Slow Eye Movements
Honnorat et al.
Arch Neurol 1995;52:462-468.
ABSTRACT  

Cerebeller Ataxia
Trouillas
Arch Neurol 1990;47:12-12.
ABSTRACT  

Cerebellar Ataxia
Klein
Arch Neurol 1989;46:1166-1166.
ABSTRACT